logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2018.01.25 2017가단34545
양수금(시효연장)청구의 소
Text

1. The Plaintiff:

A. The defendant A and B jointly share KRW 100,000,000 and the objection thereto:

B. Defendant C, D, and E

Reasons

1. (1) The facts of the reasons for the claim indicated in the attached Form No. 1 are deemed to have been led to the confessions between the Plaintiff, the Defendant Company A (hereinafter “Defendant Company”) and the Defendant B pursuant to Article 150(3) and (1) of the Civil Procedure Act, and the Plaintiff, the Defendant C, D, E, and F do not dispute between the above parties, or can be acknowledged in full view of the purport of the entire pleadings, either the evidence No. 1 and evidence No. 2-1 through No. 4.

(2) Meanwhile, according to the purport of the entire pleadings, G died on September 22, 2015, and there was his/her child C, D, E, and B as his/her inheritor. Among them, Defendant C, D, and E received an adjudication to accept a report of limited inheritance from each court; H died on February 22, 2015; Defendant B and Defendant F were his/her spouse as his/her inheritor; among them, Defendant F was subject to the adjudication to accept a report of limited inheritance approval from the court, and among them, Defendant F was subject to the adjudication to accept the report of limited inheritance approval from the court.

(3) According to the above facts of recognition, the Defendants are obligated to pay the Plaintiff the money set forth in paragraph (1) of this Article.

2. Therefore, the Plaintiff’s claim against the Defendants is accepted on the ground that all of the claims are reasonable.

(Attachment Form 3) A final and conclusive judgment stating "the cause of claim" has res judicata, but a new suit is exceptionally allowed as there are special circumstances in the interruption of prescription.

arrow